Horizon Minerals Limited (ASX: HRZ) has strengthened its gold development strategy in the Western Australian Goldfields through the acquisition of the Gordons, Mt Jewell, Malone, and Mulgarrie projects from Yandal Resources Limited (ASX: YRL). The package totals 34 granted mining, prospecting, exploration, and miscellaneous licences over ~77 km², all in close proximity to Horizon’s 100%-owned Black Swan processing facility (Figure 1).

Emyria Limited (ASX: EMD), a pioneer in evidence-based mental health care, has announced a strategic move into Queensland via a new agreement with Avive Health. This initiative marks the Company’s first Queensland-based clinic and a critical step in Emyria’s nationwide expansion strategy. The new clinic, to be located within Avive’s licensed 63-bed mental health hospital in Brisbane, will house an Empax Centre focused on treatment-resistant depression and Post-traumatic stres

Ballard Mining Limited (ASX: BM1) is not entering the gold space quietly. Born from the demerger of Delta Lithium’s gold assets, Ballard arrives on the ASX with a focused strategy, a $30M IPO war chest, and the high-grade Mt Ida Gold Project (Figure 1) in hand. Its foundation? A 1.1Moz at 3.3g/t Au JORC Resource, led by the fully permitted Baldock deposit (930koz @ 4.1g/t Au).

Boss Energy Ltd (ASX: BOE) has achieved a significant operational milestone with the successful restart and ramp-up of the Honeymoon Uranium Project in South Australia (Figure 1). As one of the few new uranium producers to emerge in a tightly held global market, Boss is positioning itself as a first mover in a sector benefiting from rising long-term uranium prices, policy momentum, and expanding nuclear power infrastructure.  

Actinogen Medical (ASX: ACW) has released its June 2025 quarterly activities report, highlighting significant progress in its clinical programs and strategic initiatives surrounding Xanamem®, the company’s lead therapeutic compound targeting Alzheimer’s disease (AD) and major depressive disorder (MDD). The June quarter was marked by clinical milestones, manufacturing scale-up, and strengthened financial flexibility through a non-dilutive funding arrangement.

Taiton Resources Limited (ASX: T88) has released a strong exploration update covering its Highway and Challenger West projects in South Australia, marking important progress on both gold and critical minerals fronts (Figure 1). The latest results highlight standout gold-in-soil values from Challenger West — including the highest recorded to date — alongside further definition of rare earth element (REE) anomalism at the Yogi prospect within the Highway Project.

This story is not about chasing hype—this is about doing the work. Some investors may say that management needs to create the hype but as long as i have know the key management of the company, this is not in their DNA. They are all about getting into the business of mineral exploration at a cost effective manner and that is maximum funds into the ground and not about funding a lifestyle company.

AML3D Limited (ASX: AL3) has marked a significant milestone in its US expansion strategy with the successful commissioning of its large-scale ARCEMY® X system at the Tennessee Valley Authority (TVA), the largest public utility in the United States. This deployment not only finalises a substantial contract valued at approximately A$1.97 million but also sets the stage for AML3D’s broader push into the energy and utilities sector.

Actinogen Medical Limited (ASX: ACW) has added another important milestone in its clinical development journey, showcasing new data that reinforces the mechanism and therapeutic promise of Xanamem® (emestedastat). The company’s Chief Medical Officer, Dr Dana Hilt, and Senior Clinical Scientist, Dr Jack Taylor, are presenting a scientific poster at the prestigious Alzheimer’s Association International Conference (AAIC 2025) in Toronto, the world’s largest platform for dementia

Heavy Rare Earths Limited (ASX: HRE) has entered into a binding Term Sheet with Havilah Resources Limited (ASX: HAV) to acquire an 80% interest in all mineral rights—excluding uranium—at the Prospect Hill project in South Australia. The project lies within the Mt Painter/Mt Babbage Inliers, a subregion of the Curnamona Craton that hosts significant polymetallic mineralisation dominated by tin (Sn), and is geologically comparable to the Gawler Craton in terms of mineralisation